Literature DB >> 29255217

Congenital adrenal hyperplasia causing hypertension: an illustrative review.

Laura Hinz1, Daniele Pacaud2, Gregory Kline2.   

Abstract

Congenital adrenal hyperplasia (CAH) is often considered a pediatric endocrinology condition, but we present two cases of young adults who presented with hypertension. An 18-year-old woman was found to have hypertension and hypokalemia when she presented for gonadectomy for 46, XY gonadal dysgenesis. She was subsequently found to have low cortisol, elevated progesterone, and elevated aldosterone. Genetic testing confirmed 17-alpha hydroxylase deficiency (17OHD). Her case was unique in that 17OHD usually presents with hypoaldosteronism. We also present the case of a 15-year-old man (46, XX) with resistant hypertension due to 11-beta hydroxylase deficiency (11OHD) who underwent bilateral adrenalectomy for control of hypertension. The relevant literature is reviewed including the pathophysiology, clinical presentation, and treatment of the hypertensive variants of congenital adrenal hyperplasia. We also review the unique areas of hyperaldosteronism in 17OHD and the use of bilateral adrenalectomy for control of hypertension in CAH.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29255217     DOI: 10.1038/s41371-017-0002-5

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  43 in total

1.  Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency.

Authors:  Marivânia Costa-Santos; Claudio E Kater; Richard J Auchus
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

2.  Primary amenorrhoea with hypertension: undiagnosed 17-α-hydroxylase deficiency.

Authors:  Fiona L Britten; Kimberly B Ulett; Emma L Duncan; Donald A Perry-Keene
Journal:  Med J Aust       Date:  2013-10-21       Impact factor: 7.738

Review 3.  Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.

Authors:  Krupali Bulsari; Henrik Falhammar
Journal:  Endocrine       Date:  2016-12-07       Impact factor: 3.633

4.  17-hydroxylation deficiency in man.

Authors:  E G Biglieri; M A Herron; N Brust
Journal:  J Clin Invest       Date:  1966-12       Impact factor: 14.808

5.  The unique patterns of plasma aldosterone and 18-hydroxycorticosterone concentrations in the 17 alpha-hydroxylase deficiency syndrome.

Authors:  C E Kater; E G Biglieri; N Brust; B Chang; J Hirai
Journal:  J Clin Endocrinol Metab       Date:  1982-08       Impact factor: 5.958

6.  A new variant of 17 alpha-hydroxylase deficiency with hyperaldosteronism in two Japanese sisters.

Authors:  S Monno; N Takasu
Journal:  Endocrinol Jpn       Date:  1989-04

7.  Rare causes of adrenocortical hypertension.

Authors:  E G Biglieri
Journal:  Cardiology       Date:  1985       Impact factor: 1.869

8.  Mutation R96W in cytochrome P450c17 gene causes combined 17 alpha-hydroxylase/17-20-lyase deficiency in two French Canadian patients.

Authors:  N Laflamme; J F Leblanc; J Mailloux; N Faure; F Labrie; J Simard
Journal:  J Clin Endocrinol Metab       Date:  1996-01       Impact factor: 5.958

9.  Bilateral adrenalectomy for severe hypertension in congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency: long term follow-up.

Authors:  M Kacem; A Moussa; I Khochtali; R Nabouli; Y Morel; A Zakhama
Journal:  Ann Endocrinol (Paris)       Date:  2009-02-04       Impact factor: 2.478

10.  Height augmentation in 11β-hydroxylase deficiency congenital adrenal hyperplasia.

Authors:  Munier A Nour; Danièle Pacaud
Journal:  Int J Pediatr Endocrinol       Date:  2015-05-15
View more
  8 in total

Review 1.  Does treatment-resistant hypertension exist in children? A review of the evidence.

Authors:  Ian Macumber; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2019-05-30       Impact factor: 3.714

2.  Monogenic forms of low-renin hypertension: clinical and molecular insights.

Authors:  Priyanka Khandelwal; Jaap Deinum
Journal:  Pediatr Nephrol       Date:  2021-08-20       Impact factor: 3.651

3.  17α-Hydroxylase/17,20-Lyase Deficiency in 46,XY: Our Experience and Review of Literature.

Authors:  Madhur Maheshwari; Sneha Arya; Anurag Ranjan Lila; Vijaya Sarathi; Rohit Barnabas; Khushnandan Rai; Vishwambhar Vishnu Bhandare; Saba Samad Memon; Manjiri Pramod Karlekar; Virendra Patil; Nalini S Shah; Ambarish Kunwar; Tushar Bandgar
Journal:  J Endocr Soc       Date:  2022-01-29

Review 4.  Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia.

Authors:  Mattia Barbot; Pierluigi Mazzeo; Martina Lazzara; Filippo Ceccato; Carla Scaroni
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-01       Impact factor: 6.055

5.  A Multiclassifier System to Identify and Subtype Congenital Adrenal Hyperplasia Based on Circulating Steroid Hormones.

Authors:  Lei Ye; Zhiyun Zhao; Huixia Ren; Wencui Wang; Wenzhong Zhou; Sichang Zheng; Rulai Han; Jie Zhang; Haorong Li; Zhihan Wan; Chao Tang; Shouyue Sun; Weiqing Wang; Guang Ning
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

6.  17 alpha-hydroxylase deficiency: A case report of young Chinese woman with a rare gene mutation.

Authors:  Li Hui Han; Liang Wang; Xiu Yun Wu
Journal:  Clin Case Rep       Date:  2022-07-25

Review 7.  Hypokalemia: a clinical update.

Authors:  Efstratios Kardalas; Stavroula A Paschou; Panagiotis Anagnostis; Giovanna Muscogiuri; Gerasimos Siasos; Andromachi Vryonidou
Journal:  Endocr Connect       Date:  2018-03-14       Impact factor: 3.335

8.  Flash glucose monitoring system was applied to cortisol treatment for a patient with congenital adrenal hyperplasia and 17α-hydroxylase deficiency.

Authors:  Chenyu Xiang; Minmin Han; Yi Zhang; Jianhong Yin; Li'e Pei; Jing Yang; Yunfeng Liu
Journal:  BMC Endocr Disord       Date:  2020-09-21       Impact factor: 2.763

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.